Based in Stockholm, Sweden, Single Technologies has a long tradition in fiber optic, ultra-sensitive fluorescence spectroscopy, proteomics and genomics, Our ambition is to become a leading provider of single molecule imaging technologies for the 21st century diagnostics and pharmacology.
Single is located close to Karolinska Institutet, the Royal Institute of Technology and Stockholm University – a vital research area in the field of state-of-the-art single molecule fluorescence technologies and life science, with a strongly international collaborative spirit.
We offer high quality technologies, assays and solutions related to drug discovery and diagnostics with quantitative output. We take pride in doing this in an innovative and responsible way.
Our IP-protected imaging system, unique know-how and strong international partners guarantee major competitive advantages.
Our strategy is: to accelerate innovation through collaboration with external researchers and partnering companies regardless of nationality; and to strengthen our position in key markets through the expansion of our product and service offerings by providing very high quality, ease of use and good design.
Johan Strömqvist, CEO
Bengt Sahlgren, Product Architect
Nils Wimmerstedt, Chief Financial Officer
BOARD OF DIRECTORS
Nils Wimmerstedt (Chairman), MBA, Founder & CEO BrommaTryck
Pär Nordström, M.Sc, Almi invest, Former CEO NeoDynamics
Sören Johansson, M.Sc, Former VP Elekta
Hans Johansson, M.Sc, Former VP ThermoFisher, CEO Personal Chemistry
Bengt Sahlgren, M.Sc, Founder Proximion, Founder SINGLE
Annika Bolind Bågenholm, M.Sc, Founder SINGLE
Johan Strömqvist, Ph.D, Founder SINGLE
Raoul Stubbe (Co-opted), Ph.D, Founder & CEO Proximion, Founder SINGLE